Table 1 |
||||
|
Correlation between the clinicopathologic characteristics and expression of HDGF protein in liver cancer |
||||
|
Characteristics |
n |
HDGF (%) |
P |
|
|
High expression |
Low expression |
|||
|
|
||||
|
Group |
||||
|
Cancer tissue |
137 |
73(53.3%) |
64 (46.7%) |
|
|
Normal tissue |
49 |
16(32.7%) |
33 (67.3%) |
0.011 |
|
Gender |
||||
|
Male |
87 |
51(58.6%) |
36 (41.4%) |
|
|
Female |
50 |
22(44%) |
28 (56%) |
0.112 |
|
Age(y) |
||||
|
≥50 |
69 |
36 (52.2%) |
33 (47.8%) |
|
|
< 50 |
68 |
37(54.4%) |
31(45.6%) |
0.865 |
|
Smoking |
||||
|
Yes |
47 |
24 (51.1%) |
23 (48.9%) |
|
|
No |
90 |
49 (54.4%) |
41 (45.6%) |
0.722 |
|
Drinking wine |
||||
|
Yes |
48 |
28(58.3%) |
20(41.7%) |
|
|
No |
89 |
45(50.6%) |
44(49.4%) |
0.473 |
|
HBV Infection |
||||
|
Yes |
103 |
54(52.4%) |
49(47.6%) |
|
|
No |
34 |
19(55.9%) |
15(44.1%) |
0.843 |
|
T classification |
||||
|
T1-T2 |
98 |
42 (42.9%) |
56(57.1%) |
|
|
T3-T4 |
39 |
31 (79.5%) |
8(20.5%) |
0.000 |
|
N classification |
||||
|
N0-N1 |
64 |
22 (34.4%) |
42 (65.6%) |
|
|
N2-N3 |
73 |
51 (69.9%) |
22 (30.1%) |
0.000 |
|
Distant metastasis |
||||
|
Yes |
33 |
22 (66.7%) |
11 (33.3%) |
|
|
No |
104 |
51 (49%) |
53 (51%) |
0.109 |
|
Clinical stage |
||||
|
I~II |
56 |
11(19.6%) |
45 (80.4%) |
|
|
III~IV |
81 |
62 (76.5%) |
19(23.5%) |
0.000 |
|
|
||||
|
Zhou et al. Diagnostic Pathology 2010 5:58 doi:10.1186/1746-1596-5-58 |
||||
